Correlation Between Molson Coors and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molson Coors and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molson Coors and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molson Coors Brewing and Entero Therapeutics,, you can compare the effects of market volatilities on Molson Coors and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molson Coors with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molson Coors and Entero Therapeutics,.

Diversification Opportunities for Molson Coors and Entero Therapeutics,

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Molson and Entero is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Molson Coors Brewing and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Molson Coors is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molson Coors Brewing are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Molson Coors i.e., Molson Coors and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Molson Coors and Entero Therapeutics,

Considering the 90-day investment horizon Molson Coors Brewing is expected to generate 0.2 times more return on investment than Entero Therapeutics,. However, Molson Coors Brewing is 5.03 times less risky than Entero Therapeutics,. It trades about -0.01 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.01 per unit of risk. If you would invest  5,537  in Molson Coors Brewing on October 25, 2024 and sell it today you would lose (115.00) from holding Molson Coors Brewing or give up 2.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Molson Coors Brewing  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Molson Coors Brewing 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Molson Coors Brewing has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Molson Coors is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Entero Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Entero Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Entero Therapeutics, is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Molson Coors and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molson Coors and Entero Therapeutics,

The main advantage of trading using opposite Molson Coors and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molson Coors position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Molson Coors Brewing and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world